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Clathrin-associated proteins purified from bovine brain exhibited an ultraviolet spectrum with absorbance 
maximum at 256 nm and were found to contain tightly bound nucleotide. This nucleotide was identified 
as AMP and/or ADP by thin-layer and high-performance liquid chromatographic analyses. The 
phosphorylation state of the bound nucleotide varied with storage conditions, suggesting that exchange 
with ATP might occur while a molar ratio of two nucleotides per protein molecule is maintained. This 
nucleotide binding site may play a role in the functions of clathrin-associated proteins. 
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1, INTRODUCTION 
The process of coated pit/vesicle formation is of 
major interest [l-3]. Understanding this process at 
the molecular level requires elucidation of how the 
lattice-forming protein, clathrin, interacts with 
itself and other proteins for coat assembly and 
disassembly [4-61. Clathrin exists as a trimer in 
solution, tightly associated with polypeptides of 
about 36000 and 33000 M, [7] which were isolated 
and partially characterized in our laboratories 
P991. Clathrin-associated proteins (CAPS) 
demonstrated calcium-dependent affinity for 
calmodulin [8] and co-localized with clathrin at 
both the light and electron microscope levels utiliz- 
ing specific antibodies to CAPS elicited in rabbits 
[9,10]. We here show that CAPS contain bound 
nucleotide. These data suggest that an energy- 
dependent mechanism modulated via CAPS may 
exist in the clathrin complex. 
tinuous sucrose gradients and the clathrin-CAPS 
complex was purified by column chromatography 
on Sepharose 4B columns as in [4,1 I]. The CAPS 
were prepared either directly from the crude 
clathrin extract or from purified clathrin as in [8]. 
2. MATERIALS AND METHODS 
Clathrin and CAPS were extracted from coated 
vesicles prepared by centrifugation on discon- 
The nucleotide content of clathrin and CAPS 
preparations was initially determined by thin-layer 
chromatography (TLC) of perchloric acid-treated 
samples using half-sized sheets of 
polyethyleneimine cellulose (Brinkmann In- 
struments) and solvent systems of 0.5 M LiCl con- 
taining 2 N formic acid or 0.25 M LiCl. The 
former system was used for the separation of 
mono-, di- and triphosphonucleosides and the lat- 
ter for the separation of cyclic and non-cyclic 
monophosphonucleosides. To increase the sen- 
sitivity, subsequent analyses were performed on an 
Altex model 100 high-performance liquid 
chromatography (HPLC) using a Partisil SAX 
anion exchange column (25 x 4.5 mm). The instru- 
ment was run isocratically at a flow rate of 
0.5 ml/min using 0.3 M KH2P04 (pH 4.5) to 
detect nucleoside mono- and diphosphates and 
0.75 M KH2P04 (pH 4.5) to detect nucleoside 
triphosphates [121. 
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3. RESULTS 
3.1. UV spectrum of purified CAPS 
The sodium dodecyl sulfate polyacrylamide gel 
electrophoretic profile of a number of CAPS 
preparations is illustrated in fig.1. The 
reproducibility of the procedure is evident in the 
gel patterns, which also illustrate the high degree 
of purity obtained. When such a preparation was 
scanned at about 0.1 mg/ml (determined by the 
Lowry procedure using bovine serum albumin as 
the standard) the UV absorbance spectrum showed 
a maximal absorbance at 255 nm, in contrast to 
clathrin, which had a maximum at 280 nm (fig.2). 
To determine if the spectral shift was due to the 
presence of nucleotide, the protein was denatured 
by addition of perchloric acid and the UV spec- 
trum again determined; this indicated the presence 
of nucleotide and suggested that it consisted main- 
ly of an adenine moiety. 
3.2. Detection of adenosine mono- and 
diphosphate 
Several CAP preparations were acidified with 
perchloric acid and the supernatants obtained after 
centrifugation in a Brinkman microfuge for 2 min 
Fig.1. SDS-PAGE analysis of various protein 
preparations used. Lane 1, 75 pg of clathrin 
preparation; lanes 2-9, 15 pg of a number of different 
CAPS preparations, all of which showed high purity, 
although the CAPS were not always resolved as a 
doublet. 
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Fig.2. Comparison of the UV spectrum of clathrin and 
CAPS. The UV spectrum of a 0.6 mg/ml solution of 
clathrin in 20 mM Tris (pH 7.5) buffer containing 
0.5 mM MgClz and 7 mM 2-mercaptoethanol. The 
spectrum was obtained with a Beckman 25 kinetic 
spectrophotometer scanned at 20 nm/min. The UV 
spectrum of a 0.1 mg/ml solution of CAPS in the same 
buffer and run under identical conditions. The UV 
spectrum of the neutralized supernatant was obtained 
from perchloric acid treatment of this CAP solution. A 
similar spectrum is obtained if clathrin is subjected to 
perchloric acid treatment. 
were neutralized by the addition of 5 N KOH and 
again centrifuged to remove insoluble KC104. The 
supernatant was spotted onto polyethyleneimine 
cellulose plates and developed in either 0.25 M 
LiCl or 0.5 M LiCl containing 2 N formic acid. 
These analyses showed that some preparations 
contained ADP, others AMP and in some in- 
stances a mixture of both. To exclude the possibili- 
ty that the acid treatment and/or analysis time 
might have resulted in partial hydrolysis of the 
nucleotide a more quantitative and sensitive 
method of analysis was sought. 
The high-performance liquid chromatographic 
analysis of protein extracts gave increased sen- 
sitivity using the following protocol for CAPS and 
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clathrin preparations. About 0.5 mg of CAPS or 
3 mg clathrin in 0.5 ml of 20 mM Tris buffer (pH 
7.5) was treated with 30~1 of concentrated per- 
chloric acid, left on ice for 5 min, centrifuged and 
the supernatant containing the nucleotides was 
then extracted with 750 ~1 of a 3 : 1 Freon-Alamine 
mixture for 30 min on ice with occasional vortex- 
ing [ 131. The suspension was centrifuged in a 
microfuge, the water (upper) layer was removed, 
neutralized with KOH and stored frozen until 
analyzed. The results of such analyses are given in 
table 1. When protein preparations were stored at 
4°C and analyzed 7-14 days later the nucleotide 
composition shifted from ADP to a mixture of 
ADP and AMP or to AMP. Quantitation of the 
nucleotide present in several preparations resulted 
in a molar ratio between 1 and 2, suggesting that 
up to 2 mol of nucleotide are bound since the resin 
Table 1 
Analysis of nucleotide content by HPLC 
Sample Nucleotide 
present 
Total 
(nmol) 
Molar ratio 
nucleotide/ 
protein 
CAP1 
CAP2 
CAP3 
CAP4 
CAPS 
ADP 
ADP 
ADP 
AMP 
AMP 
3.5 * 0.2 1.3 
5.2 f 0.3 1.4 
1.5 + 0.2 1.8 
5.1 f 0.2 1.9 
6.2 + 0.3 2.1 
3 Days storage at 4°C 
CAP1 ADP, AMP 
CAP2 ADP, AMP 
CAP3 ADP, AMP 
3.0 f 0.2 1.3 
4.7 f 0.3 1.2 
1.2 f 0.2 1.6 
7 Days storage at 4°C 
CAP] AMP 3.1 f 0.2 1.3 
CAP2 AMP 4.7 f 0.3 1.2 
CAP3 AMP 1.2 f 0.2 1.6 
Concentration of nucleotide was calculated from 
standard curve generated with known concentrations of 
AMP, ADP and ATP. The areas under peak for both 
known and unknown samples were integrated by 
triangulation. Protein concentration of each sample was 
determined before perchloric acid treatment, but after 
treatment with Dowex resin to ensure removal of 
unbound nucleotide. This treatment may remove some 
bound nucleotide, therefore true molar ratio is probably 
somewhat higher 
treatment is potentially capable of removing some 
bound nucleotide. 
4. DISCUSSION 
Preparations of clathrin and CAPS have been 
shown to contain tightly bound nucleotide by 3 
methods of analysis: UV spectroscopy, TLC and 
HPLC. The nucleoside phosphates identified have 
been ADP and AMP. Since storage of CAPS or 
clathrin at 4°C for several days resulted in a large 
decrease of ADP and an increase in levels of AMP, 
it appears that nucleotide hydrolysis occurred and 
possibly that ATP was, in fact, the original bound 
nucleotide. The nucleotide appears tightly bound 
and partially non-exchangeable because the pro- 
tein preparation is performed without exogenous 
nucleotide. Chromatography on Sepharose 4B of 
the proteins should have removed any unbound 
nucleotide. In addition, all concentrated protein 
fractions underwent extensive dialysis before 
storage in the absence of exogenous nucleotide. As 
an additional precautionary step, these protein 
preparations were pretreated with Dowex-Ag 1 x 4 
resin at pH 7.5 in a batch procedure immediately 
before analysis for nucleotide. The resin treatment 
was capable of decreasing 20-fold the concentra- 
tion of free nucleotide present at one millimolar 
and therefore found effective in removing any free 
nucleotide still remaining in the protein prepara- 
tion. Nevertheless, AMP was detected on clathrin 
and CAP preparations so far analyzed. On occa- 
sion, ADP was also detected, and several CAP 
preparations contained initially only this 
nucleotide. Within a few days of storage at 4”C, 
the ADP was converted to AMP. This observation 
suggests that extra precautions to stabilize the 
nucleotide present, such as inclusion of ATP dur- 
ing the purification procedure and more rapid 
storage of protein preparations in the freezer might 
result in the recovery of bound nucleotide as ATP. 
Preliminary data suggest that 2 mol of 
nucleotides are bound (see table 1) and that 1 mol 
is exchangeable with exogenously added ATP (un- 
published). These observations have important im- 
plications in the role of CAPS in the decoating pro- 
cess in lieu of the recent report of a cytosolic 
decoating factor which appears to become a func- 
tional ATPase only in the presence of the 
triskelion, possibly exerting its activity upon or in 
305 
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concert with the CAPS [14,15]; a possibility sup- 
ported by the requirement for intact CAPS to allow 
in vitro assembly of triskelions into baskets 
[16,17]. 
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